120 related articles for article (PubMed ID: 37838946)
1. Aspartyl-tRNA synthetase 2 orchestrates iron-sulfur metabolism in hematopoietic stem cells via fine-tuning alternative RNA splicing.
Gu X; Li K; Zhang M; Chen Y; Zhou J; Yao C; Zang Y; He J; Wan J; Guo B
Cell Rep; 2023 Oct; 42(10):113264. PubMed ID: 37838946
[TBL] [Abstract][Full Text] [Related]
2. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy.
van Berge L; Hamilton EM; Linnankivi T; Uziel G; Steenweg ME; Isohanni P; Wolf NI; Krägeloh-Mann I; Brautaset NJ; Andrews PI; de Jong BA; al Ghamdi M; van Wieringen WN; Tannous BA; Hulleman E; Würdinger T; van Berkel CG; Polder E; Abbink TE; Struys EA; Scheper GC; van der Knaap MS;
Brain; 2014 Apr; 137(Pt 4):1019-29. PubMed ID: 24566671
[TBL] [Abstract][Full Text] [Related]
3. Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing.
Guang S; O'Brien BM; Fine AS; Ying M; Fatemi A; Nemeth CL
Sci Rep; 2023 Aug; 13(1):13042. PubMed ID: 37563224
[TBL] [Abstract][Full Text] [Related]
4. Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation is associated with cell-type-dependent splicing of mtAspRS mRNA.
van Berge L; Dooves S; van Berkel CG; Polder E; van der Knaap MS; Scheper GC
Biochem J; 2012 Feb; 441(3):955-62. PubMed ID: 22023289
[TBL] [Abstract][Full Text] [Related]
5. DARS2 protects against neuroinflammation and apoptotic neuronal loss, but is dispensable for myelin producing cells.
Aradjanski M; Dogan SA; Lotter S; Wang S; Hermans S; Wibom R; Rugarli E; Trifunovic A
Hum Mol Genet; 2017 Nov; 26(21):4181-4189. PubMed ID: 28985337
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mutations causing LBSL affect mitochondrial aspartyl-tRNA synthetase in diverse ways.
van Berge L; Kevenaar J; Polder E; Gaudry A; Florentz C; Sissler M; van der Knaap MS; Scheper GC
Biochem J; 2013 Mar; 450(2):345-50. PubMed ID: 23216004
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.
Wongkittichote P; Magistrati M; Shimony JS; Smyser CD; Fatemi SA; Fine AS; Bellacchio E; Dallabona C; Shinawi M
Mol Genet Metab; 2022 Aug; 136(4):260-267. PubMed ID: 35820270
[TBL] [Abstract][Full Text] [Related]
8. Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation.
Synofzik M; Schicks J; Lindig T; Biskup S; Schmidt T; Hansel J; Lehmann-Horn F; Schöls L
J Med Genet; 2011 Oct; 48(10):713-5. PubMed ID: 21749991
[TBL] [Abstract][Full Text] [Related]
9. Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing.
Guang S; O'Brien B; Fine AS; Ying M; Fatemi A; Nemeth C
Res Sq; 2023 Feb; ():. PubMed ID: 36909591
[TBL] [Abstract][Full Text] [Related]
10. DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis.
Isohanni P; Linnankivi T; Buzkova J; Lönnqvist T; Pihko H; Valanne L; Tienari PJ; Elovaara I; Pirttilä T; Reunanen M; Koivisto K; Marjavaara S; Suomalainen A
J Med Genet; 2010 Jan; 47(1):66-70. PubMed ID: 19592391
[TBL] [Abstract][Full Text] [Related]
11. DARS2 is indispensable for Purkinje cell survival and protects against cerebellar ataxia.
Rumyantseva A; Motori E; Trifunovic A
Hum Mol Genet; 2020 Oct; 29(17):2845-2854. PubMed ID: 32766765
[TBL] [Abstract][Full Text] [Related]
12. Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma.
Liu XS; Liu ZY; Zeng DB; Hu J; Chen XL; Gu JL; Gao Y; Pei ZJ
Aging (Albany NY); 2024 Feb; 16(4):3934-3954. PubMed ID: 38382106
[TBL] [Abstract][Full Text] [Related]
13. Released selective pressure on a structural domain gives new insights on the functional relaxation of mitochondrial aspartyl-tRNA synthetase.
Schwenzer H; Scheper GC; Zorn N; Moulinier L; Gaudry A; Leize E; Martin F; Florentz C; Poch O; Sissler M
Biochimie; 2014 May; 100():18-26. PubMed ID: 24120687
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart.
Dogan SA; Pujol C; Maiti P; Kukat A; Wang S; Hermans S; Senft K; Wibom R; Rugarli EI; Trifunovic A
Cell Metab; 2014 Mar; 19(3):458-69. PubMed ID: 24606902
[TBL] [Abstract][Full Text] [Related]
15. Neuronal ablation of mt-AspRS in mice induces immune pathway activation prior to severe and progressive cortical and behavioral disruption.
Nemeth CL; Tomlinson SN; Rosen M; O'Brien BM; Larraza O; Jain M; Murray CF; Marx JS; Delannoy M; Fine AS; Wu D; Trifunovic A; Fatemi A
Exp Neurol; 2020 Apr; 326():113164. PubMed ID: 31887305
[TBL] [Abstract][Full Text] [Related]
16. A human pathology-related mutation prevents import of an aminoacyl-tRNA synthetase into mitochondria.
Messmer M; Florentz C; Schwenzer H; Scheper GC; van der Knaap MS; Maréchal-Drouard L; Sissler M
Biochem J; 2011 Feb; 433(3):441-6. PubMed ID: 21121901
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.
Scheper GC; van der Klok T; van Andel RJ; van Berkel CG; Sissler M; Smet J; Muravina TI; Serkov SV; Uziel G; Bugiani M; Schiffmann R; Krägeloh-Mann I; Smeitink JA; Florentz C; Van Coster R; Pronk JC; van der Knaap MS
Nat Genet; 2007 Apr; 39(4):534-9. PubMed ID: 17384640
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination.
Fine AS; Nemeth CL; Kaufman ML; Fatemi A
J Neurodev Disord; 2019 Dec; 11(1):29. PubMed ID: 31839000
[TBL] [Abstract][Full Text] [Related]
19. Leucoencephalopathy with brain stem and spinal cord involvement and lactate elevation: a novel mutation in the DARS2 gene.
Yelam A; Nagarajan E; Chuquilin M; Govindarajan R
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30635318
[TBL] [Abstract][Full Text] [Related]
20. Dhx38 is required for the maintenance and differentiation of erythro-myeloid progenitors and hematopoietic stem cells by alternative splicing.
Tu J; Yu S; Li J; Ren M; Zhang Y; Luo J; Sun K; Lv Y; Han Y; Huang Y; Ren X; Jiang T; Tang Z; Williams MTS; Lu Q; Liu M
Development; 2022 Sep; 149(17):. PubMed ID: 35929537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
